QA_75H70726Q00047 Amend 0001_.pdf
PDF 106 KB Posted
- Attached to
- Solicitation 75H70726Q00047_Skin Graft Products for Wound Care - Zuni Comprehensive Community Health Center
- Solicitation number
- Solicitation_75H70726Q00047
About this file
This document is an amendment providing Questions and Answers (Q&A) clarification for a federal solicitation and extends the proposal due date to July 23, 2026, at 12:00 PM (MT).
The amendment addresses four key questions regarding product requirements and submission procedures. First, regarding product substitution, the Government requires a human placental membrane wound covering meeting or exceeding salient characteristics in Section C; products failing to meet these minimum requirements will be rejected as technically unacceptable. Second, quoters must submit one quotation identifying a single proposed product; multiple or alternative product offerings within one quotation will not be evaluated. Third, concerning shelf-life requirements, the Government has not established a minimum remaining shelf-life requirement in specific days or months; however, products must be delivered with adequate remaining shelf life to support clinical use upon receipt consistent with Section C specifications. Fourth, the solicitation is issued on a Brand Name or Equal basis, allowing quoters to propose either the identified brand-name product or an equal product meeting or exceeding all salient characteristics. Quoters proposing equal products must provide sufficient technical documentation demonstrating compliance with all salient characteristics.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| Sol_75H70726Q00047_Amd_0001.pdf | ||
| Sol_75H70726Q00047 terms and conditions.pdf | ||
| QA_.docx | DOCX document | |
| Past Performance Survey_Sol 75H70726Q00047.docx | DOCX document | |
| IHS IEE Representation Form_Jan 2022_508 Compliant.pdf | ||
| Fillable pricing table_.docx | DOCX document |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Amend 0001 – To provide Questions and Answers (Q&A) and extend the due date to July 23, 2026, at 12:00
PM (MT).
Solicitation Page #
Section # Section Title Question Answer
5 of 15 3 Salient
Characteristics
Could the Government please clarify whether an offeror may submit a proposal for an autologous wound care system in lieu of the specified human placental membrane product under this solicitation?
The Government's minimum requirement is for a human placental membrane wound covering that meets or exceeds the salient characteristics identified in Section C. Products that do not satisfy those minimum requirements will not be considered technically acceptable.
11 of 15 L
INSTRUCTIONS TO
QUOTERS
Could the Government please clarify whether an offeror may submit a single proposal that includes two alternative product offerings, or if each product must be submitted as a separate proposal?
Each quoter shall submit one quotation identifying one proposed product. Multiple or alternative product offerings within a single quotation will not be evaluated.
Evaluation Method – Technical
Specifications
M – EVALUATION
FACTORS FOR
AWARD
Could the Government please clarify the required shelf-life requirement for products offered under this solicitation, including the minimum remaining shelf-life expected at the time of delivery?
The Government has not established a minimum remaining shelf-life requirement expressed in days or months. Products shall be delivered with adequate remaining shelf life to support clinical use upon receipt, consistent with Section C of the solicitation.
Is the product listed the branded item you need, or can you submit a comparable item?
The solicitation is issued on a Brand Name or Equal basis.
Quoters may propose either the identified brand-name product or an equal product that meets or exceeds all salient characteristics identified in Section C.
Quoters offering an equal product shall provide sufficient technical documentation demonstrating compliance with all salient characteristics.
File details come from the government source that posted it. Updated .